Alternative Transcripts and 3′UTR Elements Govern the Incorporation of Selenocysteine into Selenoprotein S

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Bubenik, Jodi L ^a   Miniard, Angela C ^a   Driscoll, Donna M ^a,b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b CLEVELAND CLINIC LERNER COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; SELENOCYSTEINE; SELENOPROTEIN; SELENOPROTEIN S; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ARTICLE; BINDING AFFINITY; BIOINFORMATICS; CODON; CONTROLLED STUDY; ENDOPLASMIC RETICULUM; GENE EXPRESSION REGULATION; GENE INSERTION SEQUENCE; GENETIC CODE; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; HUMAN; HUMAN CELL; IN VITRO STUDY; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; SELENOPROTEIN S GENE; SEQUENCE ANALYSIS;

3' UNTRANSLATED REGIONS; CELL LINE; CODON, TERMINATOR; HUMANS; RNA, MESSENGER; SELENOCYSTEINE; SELENOPROTEINS;

EID: 84876183504     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0062102     Document Type: Article

References (61)

1. Berry MJ, Banu L, Chen YY, Mandel SJ, Kieffer JD, et al. (1991) Recognition of UGA as a selenocysteine codon in type I deiodinase requires sequences in the 3′ untranslated region. Nature 353: 273-276.
2. Copeland PR, Fletcher JE, Carlson BA, Hatfield DL, Driscoll DM, (2000) A novel RNA binding protein, SBP2, is required for the translation of mammalian selenoprotein mRNAs. EMBO J 19: 306-314.
3. Fletcher JE, Copeland PR, Driscoll DM, Krol A, (2001) The selenocysteine incorporation machinery: interactions between the SECIS RNA and the SECIS-binding protein SBP2. RNA 7: 1442-1453.
4. Allmang C, Carbon P, Krol A, (2002) The SBP2 and 15.5 kD/Snu13p proteins share the same RNA binding domain: identification of SBP2 amino acids important to SECIS RNA binding. RNA 8: 1308-1318.
5. Lee BJ, Worland PJ, Davis JN, Stadtman TC, Hatfield DL, (1989) Identification of a selenocysteyl-tRNA(Ser) in mammalian cells that recognizes the nonsense codon, UGA. J Biol Chem 264: 9724-9727.
6. Carlson BA, Martin-Romero FJ, Kumaraswamy E, Moustafa ME, Zhi H, et al. (2001) Mammalian selenocysteine tRNA. In: Hatfield DL, editor. Selenium: Its Molecular Biology and Role in Human Health. Norwell, Massachusetts: Kluwer Academic Publishers. pp. 23-32.
7. Tujebajeva RM, Copeland PR, Xu XM, Carlson BA, Harney JW, et al. (2000) Decoding apparatus for eukaryotic selenocysteine insertion. EMBO Rep 1: 158-163.
8. Fagegaltier D, Hubert N, Yamada K, Mizutani T, Carbon P, et al. (2000) Characterization of mSelB, a novel mammalian elongation factor for selenoprotein translation. EMBO J 19: 4796-4805.
9. Chavatte L, Brown BA, Driscoll DM, (2005) Ribosomal protein L30 is a component of the UGA-selenocysteine recoding machinery in eukaryotes. Nat Struct Mol Biol 12: 408-416.
10. Miniard AC, Middleton LM, Budiman ME, Gerber CA, Driscoll DM, (2010) Nucleolin binds to a subset of selenoprotein mRNAs and regulates their expression. Nucleic Acids Res 38: 4807-4820.
11. Budiman ME, Bubenik JL, Miniard AC, Middleton LM, Gerber CA, et al. (2009) Eukaryotic initiation factor 4a3 is a selenium-regulated RNA-binding protein that selectively inhibits selenocysteine incorporation. Mol Cell 35: 479-489.
12. Allmang C, Wurth L, Krol A, (2009) The selenium to selenoprotein pathway in eukaryotes: more molecular partners than anticipated. Biochim Biophys Acta 1790: 1415-1423.
13. Seeher S, Mahdi Y, Schweizer U, (2012) Post-transcriptional control of selenoprotein biosynthesis. Curr Protein Pept Sci 13: 337-346.
14. Mariotti M, Ridge PG, Zhang Y, Lobanov AV, Pringle TH, et al. (2012) Composition and evolution of the vertebrate and mammalian selenoproteomes. PLoS One 7: e33066.
15. Taskov K, Chapple C, Kryukov GV, Castellano S, Lobanov AV, et al. (2005) Nematode selenoproteome: the use of the selenocysteine insertion system to decode one codon in an animal genome? Nucleic Acids Res 33: 2227-2238.
16. Kryukov GV, Castellano S, Novoselov SV, Lobanov AV, Zehtab O, et al. (2003) Characterization of mammalian selenoproteomes. Science 300: 1439-1443.
17. Walder K, Kantham L, McMillan JS, Trevaskis J, Kerr L, et al. (2002) Tanis: a link between type 2 diabetes and inflammation? Diabetes 51: 1859-1866.
18. Gao Y, Feng HC, Walder K, Bolton K, Sunderland T, et al. (2004) Regulation of the selenoprotein SelS by glucose deprivation and endoplasmic reticulum stress- SelS is a novel glucose-regulated protein. FEBS Lett 563: 185-190.
19. Shchedrina VA, Everley RA, Zhang Y, Gygi SP, Hatfield DL, et al. (2011) Selenoprotein K binds multiprotein complexes and is involved in the regulation of endoplasmic reticulum homeostasis. J Biol Chem 286: 42937-42948.
20. Christensen LC, Jensen NW, Vala A, Kamarauskaite J, Johansson L, et al. (2012) The human selenoprotein VCP-interacting membrane protein (VIMP) is non-globular and harbors a reductase function in an intrinsically disordered region. J Biol Chem 287: 26388-26399.
21. Ye Y, Shibata Y, Yun C, Ron D, Rapoport TA, (2004) A membrane protein complex mediates retro-translocation from the ER lumen into the cytosol. Nature 429: 841-847.
22. Kim KH, Gao Y, Walder K, Collier GR, Skelton J, et al. (2007) SEPS1 protects RAW264.7 cells from pharmacological ER stress agent-induced apoptosis. Biochem Biophys Res Commun 354: 127-132.
23. Fradejas N, Serrano-Perez Mdel C, Tranque P, Calvo S, (2011) Selenoprotein S expression in reactive astrocytes following brain injury. Glia 59: 959-972.
24. Kelly E, Greene CM, Carroll TP, McElvaney NG, O'Neill SJ, (2009) Selenoprotein S/SEPS1 modifies endoplasmic reticulum stress in Z variant alpha1-antitrypsin deficiency. J Biol Chem 284: 16891-16897.
25. Fradejas N, Pastor MD, Mora-Lee S, Tranque P, Calvo S, (2008) SEPS1 gene is activated during astrocyte ischemia and shows prominent antiapoptotic effects. J Mol Neurosci 35: 259-265.
26. Du S, Liu H, Huang K, (2010) Influence of SelS gene silence on beta-Mercaptoethanol-mediated endoplasmic reticulum stress and cell apoptosis in HepG2 cells. Biochim Biophys Acta 1800: 511-517.
27. Gao Y, Hannan NR, Wanyonyi S, Konstantopolous N, Pagnon J, et al. (2006) Activation of the selenoprotein SEPS1 gene expression by pro-inflammatory cytokines in HepG2 cells. Cytokine 33: 246-251.
28. Curran JE, Jowett JB, Elliott KS, Gao Y, Gluschenko K, et al. (2005) Genetic variation in selenoprotein S influences inflammatory response. Nat Genet 37: 1234-1241.
29. Yoshida H, (2007) ER stress and diseases. FEBS J 274: 630-658.
30. Hotamisligil GS, (2010) Endoplasmic reticulum stress and the inflammatory basis of metabolic disease. Cell 140: 900-917.
31. Wang S, Kaufman RJ, (2012) The impact of the unfolded protein response on human disease. J Cell Biol 197: 857-867.
32. Mehta A, Rebsch CM, Kinzy SA, Fletcher JE, Copeland PR, (2004) Efficiency of mammalian selenocysteine incorporation. J Biol Chem 279: 37852-37859.
33. Bakheet T, Williams BR, Khabar KS, (2006) ARED 3.0: the large and diverse AU-rich transcriptome. Nucleic Acids Res 34: D111-114.
34. Gruber AR, Lorenz R, Bernhart SH, Neubock R, Hofacker IL, (2008) The Vienna RNA websuite. Nucleic Acids Res 36: W70-74.
35. Barreau C, Paillard L, Osborne HB, (2005) AU-rich elements and associated factors: are there unifying principles? Nucleic Acids Res 33: 7138-7150.
36. Hofacker IL, (2007) RNA consensus structure prediction with RNAalifold. Methods Mol Biol 395: 527-544.
37. Kerem A, Kronman C, Bar-Nun S, Shafferman A, Velan B, (1993) Interrelations between assembly and secretion of recombinant human acetylcholinesterase. J Biol Chem 268: 180-184.
38. Fra AM, Fagioli C, Finazzi D, Sitia R, Alberini CM, (1993) Quality control of ER synthesized proteins: an exposed thiol group as a three-way switch mediating assembly, retention and degradation. EMBO J 12: 4755-4761.
39. Guenzi S, Fra AM, Sparvoli A, Bet P, Rocco M, et al. (1994) The efficiency of cysteine-mediated intracellular retention determines the differential fate of secretory IgA and IgM in B and plasma cells. Eur J Immunol 24: 2477-2482.
40. Reddy P, Sparvoli A, Fagioli C, Fassina G, Sitia R, (1996) Formation of reversible disulfide bonds with the protein matrix of the endoplasmic reticulum correlates with the retention of unassembled Ig light chains. EMBO J 15: 2077-2085.
41. Otsu M, Bertoli G, Fagioli C, Guerini-Rocco E, Nerini-Molteni S, et al. (2006) Dynamic retention of Ero1alpha and Ero1beta in the endoplasmic reticulum by interactions with PDI and ERp44. Antioxid Redox Signal 8: 274-282.
42. Sitia R, Neuberger M, Alberini C, Bet P, Fra A, et al. (1990) Developmental regulation of IgM secretion: the role of the carboxy-terminal cysteine. Cell 60: 781-790.
43. Gao Y, Pagnon J, Feng HC, Konstantopolous N, Jowett JB, et al. (2007) Secretion of the glucose-regulated selenoprotein SEPS1 from hepatoma cells. Biochem Biophys Res Commun 356: 636-641.
44. Gao Y, Walder K, Sunderland T, Kantham L, Feng HC, et al. (2003) Elevation in Tanis expression alters glucose metabolism and insulin sensitivity in H4IIE cells. Diabetes 52: 929-934.
45. Barbosa-Morais NL, Irimia M, Pan Q, Xiong HY, Gueroussov S, et al. (2012) The evolutionary landscape of alternative splicing in vertebrate species. Science 338: 1587-1593.
46. Howard MT, Aggarwal G, Anderson CB, Khatri S, Flanigan KM, et al. (2005) Recoding elements located adjacent to a subset of eukaryal selenocysteine-specifying UGA codons. EMBO J 24: 1596-1607.
47. Howard MT, Moyle MW, Aggarwal G, Carlson BA, Anderson CB, (2007) A recoding element that stimulates decoding of UGA codons by Sec tRNA[Ser]Sec. RNA 13: 912-920.
48. Warf MB, Berglund JA, (2010) Role of RNA structure in regulating pre-mRNA splicing. Trends Biochem Sci 35: 169-178.
49. Gasdaska JR, Harney JW, Gasdaska PY, Powis G, Berry MJ, (1999) Regulation of human thioredoxin reductase expression and activity by 3′-untranslated region selenocysteine insertion sequence and mRNA instability elements. J Biol Chem 274: 25379-25385.
50. Karlsson HK, Tsuchida H, Lake S, Koistinen HA, Krook A, (2004) Relationship between serum amyloid A level and Tanis/SelS mRNA expression in skeletal muscle and adipose tissue from healthy and type 2 diabetic subjects. Diabetes 53: 1424-1428.
51. Seiderer J, Dambacher J, Kuhnlein B, Pfennig S, Konrad A, et al. (2007) The role of the selenoprotein S (SELS) gene-105G>A promoter polymorphism in inflammatory bowel disease and regulation of SELS gene expression in intestinal inflammation. Tissue Antigens 70: 238-246.
52. Du JL, Sun CK, Lu B, Men LL, Yao JJ, et al. (2008) Association of SelS mRNA expression in omental adipose tissue with Homa-IR and serum amyloid A in patients with type 2 diabetes mellitus. Chin Med J (Engl) 121: 1165-1168.
53. Zeng J, Du S, Zhou J, Huang K, (2008) Role of SelS in lipopolysaccharide-induced inflammatory response in hepatoma HepG2 cells. Arch Biochem Biophys 478: 1-6.
54. Latreche L, Jean-Jean O, Driscoll DM, Chavatte L, (2009) Novel structural determinants in human SECIS elements modulate the translational recoding of UGA as selenocysteine. Nucleic Acids Res 37: 5868-5880.
55. Donovan J, Copeland PR, (2012) Selenocysteine insertion sequence binding protein 2L is implicated as a novel post-transcriptional regulator of selenoprotein expression. PLoS One 7: e35581.
56. Brown CJ, Johnson AK, Dunker AK, Daughdrill GW, (2011) Evolution and disorder. Curr Opin Struct Biol 21: 441-446.
57. Driscoll DM, Chavatte L, (2004) Finding needles in a haystack. In silico identification of eukaryotic selenoprotein genes. EMBO Rep 5: 140-141.
58. Anestal K, Arner ES, (2003) Rapid induction of cell death by selenium-compromised thioredoxin reductase 1 but not by the fully active enzyme containing selenocysteine. J Biol Chem 278: 15966-15972.
59. Anestal K, Prast-Nielsen S, Cenas N, Arner ES, (2008) Cell death by SecTRAPs: thioredoxin reductase as a prooxidant killer of cells. PLoS One 3: e1846.
60. Lu J, Zhong L, Lonn ME, Burk RF, Hill KE, et al. (2009) Penultimate selenocysteine residue replaced by cysteine in thioredoxin reductase from selenium-deficient rat liver. FASEB J 23: 2394-2402.
61. Xu XM, Turanov AA, Carlson BA, Yoo MH, Everley RA, et al. (2010) Targeted insertion of cysteine by decoding UGA codons with mammalian selenocysteine machinery. Proc Natl Acad Sci U S A 107: 21430-21434.